HC Wainwright & Co. Maintains Buy on Dynavax Technologies, Raises Price Target to $28
HC Wainwright & Co. analyst Edward White maintains Dynavax Technologies (NASDAQ:DVAX) with a Buy and raises the price target from $23 to $28.
Dynavax Says COVID-19 Vaccine Developed By Biological E Using Co’s CpG 1018 Adjuvant Receives India DCGI Approval For Emergency Use
Dynavax Technologies Corporation (NASDAQ:DVAX) a biopharmaceutical company focused on developing and commercializing vaccines, today announced that Biological E reported that
Valneva Shares Soar On Securing EU COVID-19 Vaccine Deal
Valneva SE (NASDAQ: VALN) shares jumped more than 20% after winning approval from the European Commission for a deal.
64 Stocks Moving In Friday’s Mid-Day Session
Gainers
Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the estimated price range of $4-$6, for raising gross proceeds of $10 million.
Earnings Scheduled For November 4, 2021
Companies Reporting Before The Bell
• DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
21 Stocks Moving in Monday’s Pre-Market Session
Gainers
Valneva SE (NASDAQ: VALN) rose 34.4% to $37.69 in pre-market trading after the company disclosed positive Phase 3 results for inactivated, adjuvanted COVID-19 vaccine candidate VLA2001.
Valneva Reports Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001 Met Both Co-primary Endpoints
Valneva SE (NASDAQ: VALN) today announced positive topline results from the Phase 3 pivotal trial Cov-Compare of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.
Dynavax Technologies, U.S. Department Of Defense Announce Collaboration To Develop An Adjuvant Plague Vaccine Using Co’s CpG 1018 Adjuvant; Terms Not Disclosed
Dynavax Technologies Corporation (NASDAQ:DVAX), a biopharmaceutical company focused on developing and commercializing vaccines, and the U.S. Department of Defense (DOD) today announced Dynavax has executed an
